Boai NKY Pharmaceuticals Ltd (300109.SZ) stock: key figures, P/E, revenue and dividend

Materials · Commodity Chemicals · China · ISIN CNE100000SV3

Price
10.94 CNY
Market cap
6.31 bn CNY
P/E (2025)
33.57
P/S (2025)
5.36
Dividend yield
1.83 %
Net margin
16.14 %
Return on equity (ROE)
5.16 %
Return on assets (ROA)
4.35 %

Boai NKY Pharmaceuticals Ltd financials

Fiscal year20242025
Revenue1.61 bn CNY1.18 bn CNY
Gross profit750.03 m CNY539.12 m CNY
Operating income408.48 m CNY297.31 m CNY
EBIT409.60 m CNY243.99 m CNY
Net income349.68 m CNY190.09 m CNY
Diluted EPS – continuing operations0.72 CNY0.33 CNY

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Boai NKY Pharmaceuticals Ltd

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precision medicine. It also offers pharmaceutical; hazardous chemical; food additive; medical protective equipment; medical device; manufacturing of basic chemical raw materials; import and export of goods and technology; technical services; and technology development, consulting, exchange, transfer, and promotion. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.